how does a glp 1 agonist work GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus GLP-1 | Summary
Description
10.1001/jamanetworkopen.2023.14493 73 ShahwarD.BaqaiS.KhanF.KhanM
approval is not guaranteed based on the above criteria
Among GLP-1RA users, 26.36% discontinued treatment during follow-up, while 22.68% experienced interruptions
Toxicol Pathol
Efficacy and safety of Ipragliflozin as an add-on therapy to sitagliptin and Metformin in Korean patients with inadequately controlled type 2 diabetes mellitus: a randomized controlled trial
